Search

everythinglearnresearchcommunity

for

Search:↓

Microneedles are a promising method for drug delivery, offering efficient and convenient alternatives with fewer side effects.

Methotrexate is effective and well-tolerated in children for certain skin conditions but requires careful monitoring.

Pharmaceutical care in transplantation faces challenges but has promising future opportunities for better outcomes.

The congress concluded that misuse of antifungal drugs in South Asia has led to widespread treatment failure, and new approaches and regional cooperation are needed.

Platelet-rich plasma treatment may safely and effectively reduce skin lesions in psoriasis and atopic dermatitis.

Autologous platelet concentrates show promise in esthetic treatments but need more standardized research.

Mycophenolic acid effectively improved hair and nail growth in a lupus patient.

Alopecia areata needs more recognition and better treatment access in Latin America to improve patient care and outcomes.

The document encourages attending the 2023 Dermatology Nurses' Association Convention.

Understanding drug interactions, side effects, and patient-specific factors is crucial for effective dermatological care.

Indian men have 62.1% hair loss, mostly grade II vertex, and less extensive than other populations.

Cyclosporin A and FK506 can start new hair growth in mice, but ascomycin and rapamycin cannot.

JAK inhibitors show promise for treating skin conditions like eczema, hair loss, and psoriasis.

Some treatments for autoimmune hair loss work, but JAK inhibitors like tofacitinib are promising for regrowth.

Blocking JAK-STAT signaling can lead to hair growth.

New treatments for alopecia areata show promise, but standardized guidelines are needed.

Cyclosporin A helps mice grow hair by blocking a specific protein activity in skin cells.

Topical drugs and near-infrared light therapy show potential for treating alopecia.

Alopecia areata is a hair loss condition caused by immune factors and can be treated with JAK inhibitors.

Hidradenitis Suppurativa is likely an autoinflammatory disease, and better understanding its causes could improve treatments.

Blocking the Wnt pathway could lead to new treatments for cancer and tissue repair but requires careful development to avoid side effects.

No FDA-approved treatments for chemotherapy-induced hair loss existed in 2006; more research was needed.

Psoriasis worsens in winter in India due to less sunlight and dry skin, needing personalized treatment.

Active oxygen scavengers can reverse the suppression of hair cell growth caused by androgens.

Different substances affect hair and skin cell growth in various ways.

Different substances affect hair and skin cell growth in various ways, with some promoting and others inhibiting cell proliferation.

Immune cells affect hair growth and could lead to new hair loss treatments.

Skin problems from transplant drugs are common and need careful management in organ transplant patients.

Only minoxidil and finasteride are FDA-approved for hair loss, with other treatments available but less effective or with side effects.

New treatments for a chronic skin condition show promise, but individualized plans are crucial due to varying responses.